These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37808799)

  • 1. A tale of two receptors: simultaneous targeting of NMDARs and 5-HT
    Chen BK; Luna VM; Jin M; Shah A; Shannon ME; Pauers M; Williams BL; Pham V; Hunsberger HC; Gardier AM; Mendez-David I; David DJ; Denny CA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic efficacy of 5-HT
    Chen BK; Mendez-David I; Luna VM; Faye C; Gardier AM; David DJ; Denny CA
    Neuropsychopharmacology; 2020 Feb; 45(3):542-552. PubMed ID: 31600767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (
    Bulthuis NE; McGowan JC; Ladner LR; LaGamma CT; Lim SC; Shubeck CX; Brachman RA; Sydnor E; Pavlova IP; Seo DO; Drew MR; Denny CA
    bioRxiv; 2023 Nov; ():. PubMed ID: 38076870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior.
    Chen BK; Luna VM; Shannon ME; Hunsberger HC; Mastrodonato A; Stackmann M; McGowan JC; Rubinstenn G; Denny CA
    Biol Psychiatry; 2021 Oct; 90(7):458-472. PubMed ID: 34274107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice.
    Mastrodonato A; Pavlova I; Kee NC; Pham VA; McGowan JC; Mann JJ; Denny CA
    Int J Neuropsychopharmacol; 2022 Jun; 25(6):512-523. PubMed ID: 35229871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical and raphe GABA
    Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
    Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
    Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
    Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
    Chen BK; Luna VM; LaGamma CT; Xu X; Deng SX; Suckow RF; Cooper TB; Shah A; Brachman RA; Mendez-David I; David DJ; Gardier AM; Landry DW; Denny CA
    Neuropsychopharmacology; 2020 Aug; 45(9):1545-1556. PubMed ID: 32417852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.
    Fukumoto K; Iijima M; Chaki S
    Neuropsychopharmacology; 2016 Mar; 41(4):1046-56. PubMed ID: 26245499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 5-HT
    Charousaei A; Nasehi M; Babapour V; Vaseghi S; Zarrindast MR
    Behav Brain Res; 2021 Jan; 397():112933. PubMed ID: 32991927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex- and stress-dependent effects of a single injection of ketamine on open field and forced swim behavior.
    Fitzgerald PJ; Kounelis-Wuillaume SK; Gheidi A; Morrow JD; Spencer-Segal JL; Watson BO
    Stress; 2021 Nov; 24(6):857-865. PubMed ID: 33517825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm.
    Kiselycznyk C; Svenningsson P; Delpire E; Holmes A
    Neuroscience; 2011 Oct; 193():259-68. PubMed ID: 21704131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice.
    Jeevakumar V; Kroener S
    Cereb Cortex; 2016 Mar; 26(3):1117-29. PubMed ID: 25477370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress during puberty exerts sex-specific effects on depressive-like behavior and monoamine neurotransmitters in adolescence and adulthood.
    Harris EP; Villalobos-Manriquez F; Melo TG; Clarke G; O'Leary OF
    Neurobiol Stress; 2022 Nov; 21():100494. PubMed ID: 36532376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-prefrontal cyclosporine potentiates ketamine-induced fear extinction in rats.
    Mohammadi-Farani A; Tamasoki N; Rahimian R
    Exp Brain Res; 2021 May; 239(5):1401-1415. PubMed ID: 33666692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
    Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
    Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvalbumin-Positive Interneurons in the Medial Prefrontal Cortex Regulate Stress-Induced Fear Extinction Impairments in Male and Female Rats.
    Binette AN; Liu J; Bayer H; Crayton KL; Melissari L; Sweck SO; Maren S
    J Neurosci; 2023 May; 43(22):4162-4173. PubMed ID: 37127359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventral CA3 Activation Mediates Prophylactic Ketamine Efficacy Against Stress-Induced Depressive-like Behavior.
    Mastrodonato A; Martinez R; Pavlova IP; LaGamma CT; Brachman RA; Robison AJ; Denny CA
    Biol Psychiatry; 2018 Dec; 84(11):846-856. PubMed ID: 29615190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.